The androgen receptor belongs to the family of nuclear receptors and c
ontains three functional domains: a carboxy-terminal hormone binding r
egion, a central cystein rich DNA binding region and an amino-terminal
region involved in the expression of androgen regulated genes. Clonin
g of the complementary DNA encoding the androgen receptor enabled the
characterization of the molecular defects associated with androgen ins
ensitivity syndromes, X-linked disorders resulting from androgen actio
n defects in target cells. Moreover, androgen receptor gene alteration
s have been recently described in two unrelated diseases: male breast
cancer and spinal and bulbar muscular atrophy. Our group have identifi
ed 16 androgen receptor gene alterations in patients with androgen ins
ensitivity syndrome, an amino acid substitution in a patient with a pa
rtial androgen insensitivity syndrome and a breast cancer. In 2 famili
es, the molecular diagnosis of spinal and bulbar muscular atrophy has
been performed.